H. Lundbeck A/S (CPH: HLUN.A)
41.20
-0.10 (-0.24%)
Aug 30, 2024, 4:59 PM CET
H. Lundbeck Revenue
H. Lundbeck had revenue of 5.45B DKK in the quarter ending June 30, 2024, with 10.43% growth. This brings the company's revenue in the last twelve months to 20.67B, up 6.66% year-over-year. In the year 2023, H. Lundbeck had annual revenue of 19.91B with 9.13% growth.
Revenue (ttm)
20.67B
Revenue Growth
+6.66%
P/S Ratio
1.98
Revenue / Employee
3.56M
Employees
5,681
Market Cap
46.20B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 19.91B | 1.67B | 9.13% |
Dec 31, 2022 | 18.25B | 1.95B | 11.95% |
Dec 31, 2021 | 16.30B | -1.37B | -7.77% |
Dec 31, 2020 | 17.67B | 636.00M | 3.73% |
Dec 31, 2019 | 17.04B | -1.08B | -5.97% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk A/S | 258.00B |
Coloplast A/S | 26.30B |
Genmab A/S | 19.02B |
Demant A/S | 22.84B |
Zealand Pharma A/S | 367.97M |
H. Lundbeck A/S | 20.67B |
ALK-Abelló A/S | 5.18B |
Ambu A/S | 5.08B |